IVD of Drug Abuse

    Recombinant Full Length Human Cytochrome P450 3A4(Cyp3A4) Protein, His-Tagged Full L.

    🧪 RFL25689HF

    Source:  E.coli

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length:  Full Length of Mature Protein (2-503)

    Recombinant Human CYP2D6 Protein

    🧪 CYP2D6-01H

    Source:  Sf9 Cells

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Recombinant Full Length Human CYP3A4 Protein Full L.

    🧪 CYP3A4-117HF

    Source:  In Vitro Cell Free System

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length:  503 amino acids

    Recombinant Full Length Human CRP Protein, GST-tagged Full L.

    🧪 CRP-2093HF

    Source:  In Vitro Cell Free System

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length:  91 amino acids

    Recombinant Full Length Human CYP3A4 Protein, GST-tagged Full L.

    🧪 CYP3A4-2433HF

    Source:  In Vitro Cell Free System

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length:  503 amino acids

    Recombinant Rat Prolactin / PRL Protein, Monomer

    🧪 PRL-229R

    Source:  E.coli

    Species:  Rat

    Tag: 

    Conjugation: 

    Protein Length:  30-226 a.a.

    Recombinant Human ALB Protein, Animal Free

    🧪 ALB-22H

    Source:  Human Cells

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Recombinant Human ALB Protein, Animal Free

    🧪 ALB-03H

    Source:  P.pastoris

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Recombinant Full Length Human CRP Protein, C-Flag-tagged

    🧪 CRP-725HFL

    Source:  Mammalian Cells

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Coomassie blue staining of purified CRP protein.
    Recombinant Full Length Human ALB Protein, C-Flag-tagged

    🧪 ALB-872HFL

    Source:  Mammalian Cells

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Coomassie blue staining of purified ALB protein.
    Recombinant Full Length Human CYP2D6 Protein, C-Flag-tagged

    🧪 CYP2D6-1918HFL

    Source:  Mammalian Cells

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Coomassie blue staining of purified CYP2D6 protein.
    Recombinant Human CRP Protein

    🧪 CRP-0002H

    Source:  HEK293

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Recombinant Canine CRP Protein

    🧪 CRP-0043C

    Source:  HEK293

    Species:  Cattle

    Tag: 

    Conjugation: 

    Protein Length: 

    Recombinant Human PRL Protein

    🧪 PRL-0044H

    Source:  HEK293

    Species:  Human

    Tag: 

    Conjugation: 

    Protein Length: 

    Recombinant Cynomolgus Monkey ABCB1 Protein, His (Fc)-Avi-tagged

    🧪 ABCB1-9C

    Source:  HEK293

    Species:  Cynomolgus

    Tag: 

    Conjugation: 

    Protein Length: 

    0
    cart-icon
    0
    compare icon

    Drug Abuse

    Drug abuse refers to the repeated and large-scale use of drugs with dependence properties in the form of self-administration for non-medical purposes. Long-term drug abuse can produce mental and physical dependence, leading to mental confusion and abnormal behavior. A technology known as in vitro diagnostics (IVD) is an important tool for monitoring drug abuse. By collecting individual biological samples such as urine, blood, and hair, it can be detected whether specific drugs are used, as well as the amount and frequency of use. This information is important for assessing the extent, type, and risk of drug abuse and for tracking and treating drug abusers.

    IVD of Drug Abuse

    The Role of IVD in Drug Abuse Monitoring

    • Determine whether an individual has used drugs by detecting drugs or their metabolites in biological samples.
    • Help monitoring agencies better understand the current status and trends of drug abuse.
    • Provide support for the development and implementation of drug abuse prevention and treatment policies.

    Side Effect

    Drug abuse can have a wide range of side effects, which may vary depending on the substance used, the duration of use, and the individual.

    Physical Side Effects

    • Cardiovascular Issues: High blood pressure, irregular heartbeats, heart attacks.
    • Respiratory Problems: Difficulty breathing, lung diseases (especially with drugs that are smoked).
    • Neurological Issues: Stroke, seizures, brain damage.
    • Gastrointestinal Problems: Nausea, vomiting, liver damage.
    • Musculoskeletal Problems: Muscle breakdown, deteriorated bone health.
    • Immune System: Lowered immunity, making the individual more susceptible to infections.

    Addiction-Related Consequences

    • Dependence: Needing more of the drug to achieve the same effect (tolerance), leading to higher usage.
    • Withdrawal Symptoms: Physical and psychological symptoms that occur when reducing or stopping the drug.
    • Overdose: Risk of life-threatening overdose, especially with substances like opioids.

    IVD Methods for Drug Abuse

    • Immunoassay. The principle of binding specific antibodies to target drugs is used to detect drugs or their metabolites in biological samples.
    • Spectral analysis. The absorption and scattering effects of different substances on the spectrum are used to detect drugs or their metabolites in biological samples.
    • Chromatography. The difference in distribution coefficients of different substances between the stationary phase and the mobile phase is used to separate the target drug and its metabolites, and then detect the target drug and its metabolites.
    • Mass spectrometry. The target drug is ionized using an ion source, and then the target drug and its metabolites are separated and detected in a mass spectrometer.
    • Infrared spectroscopy. Detect drugs or their metabolites in biological samples using infrared spectroscopy.

    Antibodies can be used to detect drug residues or to determine whether someone has been exposed to a drug. Currently, a variety of antibodies have been developed for different drugs of abuse, such as antibodies against sedative-hypnotics, opioids, amphetamines, cocaine, etc. Creative BioMart can provide customized IVD antibody services to assist in drug abuse monitoring.

    Advantages of Our Services

    • Advanced technology platforms improve the efficiency and precision of antibody development to a certain extent.
    • Customized services. Provide personalized antibody services according to customer needs, including antigen screening, antibody optimization, drug efficacy evaluation, etc.
    • Strict quality control. There is a strict quality control system during the development process to ensure the accuracy and reliability of every link, thereby providing customers with high-quality products.

    Case Study

    Case 1: Gust SW, McCormally J. National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training. Curr Opin Psychiatry. 2018 Jul;31(4):287-293. doi: 10.1097/YCO.0000000000000426. PMID: 29771745; PMCID: PMC6050030.

    International research to inform approaches to opioid addiction is particularly important and relevant to the United States, where opioid misuse, addiction, and overdose constitute an emerging public health crisis. This article summarizes the NIDA International Program and illustrates its impact by reviewing recent articles about treatment approaches for opioid use disorders (OUD).

    Fig2. Journals that published at least five articles by former National Institute on Drug Abuse fellows, 2016–2017.

    Case 2: Ciucă Anghel DM, Nițescu GV, Tiron AT, Guțu CM, Baconi DL. Understanding the Mechanisms of Action and Effects of Drugs of Abuse. Molecules. 2023 Jun 24;28(13):4969. doi: 10.3390/molecules28134969. PMID: 37446631; PMCID: PMC10343642.

    Drug abuse and addiction are major public health concerns, with millions of people worldwide affected by the negative consequences of drug use. To better understand this complex issue, a review was conducted to examine the mechanisms of action and effects of drugs of abuse, including their acute and chronic effects, the symptoms of abstinence syndrome, as well as their cardiovascular impacts.

    Fig3. Molecular targets and primary outcomes resulting from the effects of substances of abuse on neuronal terminals.